Anbio Biotechnology (NNNN)

Anbio Biotechnology Revenue

In the year 2025, Anbio Biotechnology had annual revenue of $8.65M with 5.64% growth. Anbio Biotechnology had revenue of $4.06M in the half year ending December 31, 2025, with 11.22% growth. That makes Anbio Biotechnology the 37,980th largest company in the world by revenue and 4,996th in the United States.

• Revenue (ttm): $8.65M
• Revenue Growth: +5.64%
• P/S Ratio: 15.89
• Revenue / Employee: $320,253
• Employees: 27
• Market Cap: 143.96M

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• European Union 5.15M 59.6%
• Asia Pacific 1.52M 17.6%
• Other Regions 1.41M 16.3%
• North America 296.20K 3.4%
• South America 269.54K 3.1%

Fiscal year ended Dec 31, 2025 See the full Anbio Biotechnology breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	8.65M	461.70K	5.64%
Dec 31, 2024	8.19M	1.47M	21.95%
Dec 31, 2023	6.71M	-16.83M	-71.49%
Dec 31, 2022	23.54M	19.12M	431.67%
Dec 31, 2021	4.43M	-	-

Data Source: S&P Global Market Intelligence Last updated: Apr 7, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every six months for this company.

Update frequency:

Semi-annually

Last checked:

Oct 15, 2026

Data Sources Report a data error